Differentiated thyroid cancer

Objective: The retrospective analysis of the case files of children with differentiated thyroid carcinoma (DTC) was performed to define the disease by its presentation, clinical course and outcome of radioiodine therapy.Methods: Between 1967 to October 2002,1754 patients with thyroid cancer were treated in the Dept of Neuclear Medicine, AIIMS, out of which 122 (7%) were ≶ 20 years of age (71 girls and 51 boys). The mean age was 15.8 ± 3.6 years and the mean duration of follow-up was 90 ± 59.3 months. Mean tumor size was 4.4 cm. Histologically, 85% of the patients had papillary and rest follicular carcinoma. Cervical lymph node involvement was seen in 64%, and distant metastases, mainly pulmonary, in 23% of the patients. The presentation of the disease was very aggressive in the first decade of life with male preponderance. All but one patient in this age group had nodal and/or distant metastases; in 83.3% the disease had spread to the lymph nodes and 67% had metastases to the lungs. The post-surgery 48-hour mean radioiodine neck uptake was 10.5 ± 7.6%.Results: 94% of the residual thyroid, 88% of nodal metastases and 71% of pulmonary metastases were ablated requiring mean cumulative doses of 2.8 ± 2.7 GBq, 4.5 ± 2.7 GBq and 10.4 ± 7.9 GBq of131I, respectively. Average number of doses required for remnant, nodal and pulmonary metastases ablation were 1.3, 2.2 and 3.3, respectively. 80% of the patients with only remnant thyroid tissue and 50% with cervical lymph node metastases got ablated with a single dose of131I. Overall, 87% patients were currently free of disease. While, nine patients had nodal recurrence between surgery and radioiodine treatment, no recurrence was observed thereafter and 3 disease related deaths producing overall mortality of 2.5% (all in children ≶10 years of age) were seen in the mean follow-up of 7.5 years.Conclusion: Differentiated thyroid cancer in children and adolescents is rare but aggressive. The biological behavior differs from that in adults and is related to the age. Younger the age (≶10 years), more aggressive and widespread is the disease with male preponderance and high mortality. The Post-surgical radioiodine ablation/therapy is an important and effective adjuvant in the management of DTC in children and adolescents and even though they present with advance disease, long-term survival and overall prognosis is good.

[1]  M. Dottorini,et al.  Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  C. Magnani,et al.  Childhood cancer registry of the province of Torino, Italy: Survival, incidence, and mortality over 20 years , 2010, Cancer.

[3]  G. van Belle,et al.  Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout. , 1987, JAMA.

[4]  R. Feinmesser,et al.  Cancer of the thyroid in children and adolescents. , 1997, Clinical otolaryngology and allied sciences.

[5]  A. Samuel,et al.  Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  M. Egger,et al.  Thyroid cancer in Belarus post-Chernobyl: Improved detection or increased incidence? , 1994, Sozial- und Präventivmedizin/Social and Preventive Medicine.

[7]  W. Dichtel,et al.  Thyroid cancer in children and teenagers. , 1984, Archives of otolaryngology.

[8]  M. Bäckdahl,et al.  Thyroid carcinoma in children and adolescents , 1986, Cancer.

[9]  J. Buckwalter,et al.  Is Childhood Thyroid Cancer a Lethal Disease ? , 1975, Annals of surgery.

[10]  E. Frazell,et al.  Carcinoma of the thyroid in children. , 1969, The Surgical clinics of North America.

[11]  K. Franssila,et al.  Differentiated Follicle‐Derived Thyroid Carcinoma in Children , 1989, Acta paediatrica Scandinavica.

[12]  I. Hay,et al.  Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. , 1988, Surgery.

[13]  H. Goepfert,et al.  Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. , 1990, American journal of surgery.

[14]  M. Pelizzo,et al.  Thyroid Cancer in Children and Adolescents , 1994, Tumori.

[15]  G. Holcomb,et al.  Long-term experience with childhood thyroid carcinoma. , 1979, Journal of pediatric surgery.

[16]  N. Laurian,et al.  Adolescent versus adult thyroid carcinoma , 1986, The Laryngoscope.

[17]  M. Massimino,et al.  Primary thyroid carcinoma in children: a retrospective study of 20 patients. , 1995, Medical and pediatric oncology.

[18]  Michael R. Tuttle,et al.  Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults , 1998, Clinical endocrinology.

[19]  J. Buckwalter,et al.  Cancer of the thyroid in youth , 2005, World Journal of Surgery.

[20]  C. Bal,et al.  Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone , 2001, Nuclear medicine communications.

[21]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[22]  F. Pacini Thyroid cancer in children and adolescents , 1988, Surgery.

[23]  L. Woolner,et al.  Management of the child with thyroidal carcinoma. , 1960, Journal of the American Medical Association.

[24]  H. S. Hansen,et al.  Thyroid cancer in children and adolescents in Denmark. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[26]  C. Sklar,et al.  Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. , 2000, Journal of pediatric surgery.

[27]  M. Brennan,et al.  Recurrence and morbidity in differentiated thyroid carcinoma in children. , 1988, Surgery.

[28]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[29]  C. Bal,et al.  Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma , 1996, Cancer.

[30]  A. Pontecorvi,et al.  Thyroid carcinoma in children and adolescents , 1997, European Journal of Pediatrics.

[31]  G. Vassal,et al.  Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. , 1987, The Journal of clinical endocrinology and metabolism.

[32]  F. Juhász,et al.  Special features of childhood and juvenile thyroid carcinomas , 1996, Surgery Today.

[33]  I. Rosen,et al.  Aggressive thyroid cancer in low-risk age population. , 1987, Surgery.

[34]  E L SOCOLOW,et al.  Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki. , 1963, The New England journal of medicine.

[35]  T. Abelin,et al.  Pathomorphological findings in thyroid cancers of children from the Republic of Belarus: a study of 86 cases occurring between 1986 (‘post‐Chernobyl’) and 1991 , 1992, Histopathology.

[36]  J. Letarte,et al.  A twenty-year experience with thyroid carcinoma in children. , 1988, Journal of pediatric surgery.

[37]  S. Kingman Thyroid cancer rises after Chernobyl. , 1992, BMJ.